JOINT FILING AGREEMENT
Exhibit 99.3
In accordance with Rule 13d-1(k)(1) under the Securities Exchange Act of 1934, as amended, the persons named below agree to the joint filing of a statement on Schedule 13D (including amendments thereto) with respect to the Common Stock of Merrimack Pharmaceuticals. and further agree that this Joint Filing Agreement be included as an Exhibit thereto. In evidence thereof, the undersigned, being duly authorized, have executed this Joint Filing Agreement this 19th day of September 2019.
| Newtyn Management, LLC | ||
| By: | /s/ Xxxx X. Xxxx Xxxx X. Xxxx, Managing Member | |
| Newtyn Partners, LP | ||
| By: | Newtyn Management, LLC | |
| Its: | Investment Manager | |
| By: | /s/ Xxxx X. Xxxx Xxxx X. Xxxx, Managing Member |
| Newtyn Capital Partners, LP | ||
| By: Ledo Capital, LLC | ||
| Its: | General Partner | |
| By: | /s/ Xxxx X. Xxxx Xxxx X. Xxxx, Managing Member |
| Ledo Capital, LLC | ||
| By: | /s/ Xxxx X. Xxxx Xxxx X. Xxxx, Managing Member | |
| /s/ Xxxx X. Xxxx | ||
| Xxxx X. Xxxx | ||
